AERIE PHARMACEUTICALS, INC.
Dead / Cancelled — Cancelled — Section 8 (as of 02 Jan 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88228143
- Registration number
- 5781737
- Mark type
- Design + words
- Filed
- 13 Dec 2018
- Published for opposition
- 02 Apr 2019
- Registered
- 18 Jun 2019
- Attorney of record
- Melissa Atherton
Goods and services
- Class 042 — Scientific and technological services: Research and development services for others in the field of ophthalmology, medicinal chemistry, cell biology, and pharmacology; conducting research and clinical trials for others relating to the fields of ophthalmology, medicinal chemistry, cell biology, and pharmacology
Owner
- ALCON INC., Fribourg, CH
- Aerie Pharmaceuticals, Inc., Bedminster, NJ, US
- Aerie Pharmaceuticals, Inc., Bedminster, NJ, US
- Aerie Pharmaceuticals, Inc., Bedminster, NJ, US
Prior registrations
Prosecution history
- 02 Jan 2026 — CANCELLED SEC. 8 (6-YR)
- 18 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Feb 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Mar 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Apr 2019 — PUBLISHED FOR OPPOSITION
- 13 Mar 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED